Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Nathan Clark

TitleLecturer
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Extended Studies Program

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Clark NP, Hoang K, Delate T, Horn JR, Witt DM. Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants. Clin Appl Thromb Hemost. 2017 Jan 01; 1076029616687849. PMID: 28118749.
      View in: PubMed
    2. Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE. Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan; 41(1):187-205. PMID: 26780746.
      View in: PubMed
    3. Delate T, Meisinger SM, Witt DM, Jenkins D, Douketis JD, Clark NP. Bridge Therapy Outcomes in Patients With Mechanical Heart Valves. Clin Appl Thromb Hemost. 2016 Jan 01; 1076029616669786. PMID: 27655997.
      View in: PubMed
    4. Meyer MR, Witt DM, Delate T, Johnson SG, Fang M, Go A, Clark NP. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. Thromb Res. 2015 Dec; 136(6):1160-4. PMID: 26477821.
      View in: PubMed
    5. Witt DM, Clark NP, Martinez K, Schroeder A, Garcia D, Crowther MA, Ageno W, Dentali F, Ye X, Hylek E, Delate T. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Thromb Res. 2015 Nov; 136(5):1040-4. PMID: 26454758.
      View in: PubMed
    6. Clark NP, Witt DM, Davies LE, Saito EM, McCool KH, Douketis JD, Metz KR, Delate T. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. JAMA Intern Med. 2015 Jul; 175(7):1163-8. PMID: 26010033.
      View in: PubMed
    7. Martinez K, Kosirog E, Billups SJ, Clark NP, Delate T, Witt DM. Clinical outcomes and adherence to guideline recommendations during the initial treatment of acute venous thromboembolism. Ann Pharmacother. 2015 Aug; 49(8):869-75. PMID: 25931575.
      View in: PubMed
    8. Jenner KM, Simmons BJ, Delate T, Clark NP, Kurz D, Witt DM. An Education Program for Patient Self-Management of Warfarin. Perm J. 2015; 19(4):33-8. PMID: 26517434.
      View in: PubMed
    9. Cho SE, Delate T, Witt DM, Clark NP. Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplasty. Thromb Res. 2015 Feb; 135(2):267-71. PMID: 25555318.
      View in: PubMed
    10. Riggs CS, Delate T, Clark NP. Supratherapeutic international normalized ratios in warfarin-treated patients who receive a highly potentiating antimicrobial course--reply. JAMA Intern Med. 2014 Jul; 174(7):1200-1. PMID: 25003888.
      View in: PubMed
    11. Clark NP, Delate T, Riggs CS, Witt DM, Hylek EM, Garcia DA, Ageno W, Dentali F, Crowther MA. Warfarin interactions with antibiotics in the ambulatory care setting. JAMA Intern Med. 2014 Mar; 174(3):409-16. PMID: 24445404.
      View in: PubMed
    12. Witt DM, Delate T, Hylek EM, Clark NP, Crowther MA, Dentali F, Ageno W, Martinez KD, Garcia DA. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes. Thromb Res. 2013; 132(6):770-5. PMID: 24521790.
      View in: PubMed
    13. Witt DM, Delate T, Clark NP, Garcia DA, Hylek EM, Ageno W, Dentali F, Crowther MA. Nonadherence with INR monitoring and anticoagulant complications. Thromb Res. 2013 Aug; 132(2):e124-30. PMID: 23800635.
      View in: PubMed
    14. Clark NP. Frequency of monitoring, non-adherence, and other topics dear to an anticoagulation clinic provider. J Thromb Thrombolysis. 2013 Apr; 35(3):320-4. PMID: 23494486.
      View in: PubMed
    15. Clark NP, Cho SE, Delate T, Witt DM. Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty. Thromb Res. 2013 May; 131(5):390-5. PMID: 23522854.
      View in: PubMed
    16. Simmons BJ, Jenner KM, Delate T, Clark NP, Kurz D, Witt DM. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring. Pharmacotherapy. 2012 Dec; 32(12):1078-84. PMID: 23112110.
      View in: PubMed
    17. Witt DM, Delate T, Garcia DA, Clark NP, Hylek EM, Ageno W, Dentali F, Crowther MA. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012 Oct 22; 172(19):1484-91. PMID: 22987143.
      View in: PubMed
    18. Dentali F, Marchesi C, Giorgi Pierfranceschi M, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011 Sep; 106(3):429-38. PMID: 21800002.
      View in: PubMed
    19. Crowther MA, Garcia D, Ageno W, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Schulman S, Kovacs M, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study. Thromb Haemost. 2010 Jul; 104(1):118-21. PMID: 20458438.
      View in: PubMed
    20. Clark NP, Delate T, Cleary SJ, Witt DM. Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy. Pharmacotherapy. 2010 Apr; 30(4):369-74. PMID: 20334457.
      View in: PubMed
    21. Clark NP, Delate T, Cleary SJ, Witt DM. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy. Thromb Res. 2010 May; 125(5):402-5. PMID: 19699510.
      View in: PubMed
    22. Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood. 2009 Jul 30; 114(5):952-6. PMID: 19439733.
      View in: PubMed
    23. Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009 Mar 03; 150(5):293-300. PMID: 19258557.
      View in: PubMed
    24. Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacotherapy. 2008 Aug; 28(8):960-7. PMID: 18657012.
      View in: PubMed
    25. Clark NP, Delate T, Witt DM, Parker S, McDuffie R. A descriptive evaluation of unfractionated heparin use during pregnancy. J Thromb Thrombolysis. 2009 Apr; 27(3):267-73. PMID: 18327536.
      View in: PubMed
    Clark's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)